Efficacy of 5-(2-aroyl)aryloxy methyl-2-phenyl-1,3,4-oxadiazoles as antibacterial and antifungal agents by Begum, A. B. et al.
© 2013 Bushra  Begum A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License -NonCommercial-ShareAlike 
Unported License (http://creativecommons.org/licenses/by-nc-sa/3.0/). 
 
 
 
 
Journal of Applied Pharmaceutical Science Vol. 3 (11), pp. 105-109, November, 2013 
Available online at http://www.japsonline.com 
DOI: 10.7324/JAPS.2013.31119 
ISSN 2231-3354   
 
Efficacy of 5-(2-aroyl)aryloxy methyl-2-phenyl-1,3,4-oxadiazoles as 
antibacterial and antifungal agents 
 
Bushra  Begum A1,2, Noor Fatima Khanum3, Naveen P1, Lakshmi Ranganatha V1, Asha MS1 and Shaukath Ara 
Khanum1* 
1*Department of Chemistry, Yuvaraja’s college, University of Mysore, Mysore Karnataka,  India;  
2Department of Chemistry, D.Banumaih’s  P U Science College, Mysore, Karnataka, India; 
3Department of Food Science and Nutrition, Maharani’s Science College for Women,   Mysore, Karnataka, India. 
 
 
 
 
ARTICLE INFO 
 
 
 
ABSTRACT 
 
Article history: 
Received on: 17/09/2013 
Revised on: 11/10/2013 
Accepted on: 19/11/2013 
Available online: 29/11/2013 
 
 
 
 
 
 
 
 
 
 
 
Research and development of potent and effective antimicrobial agents represent one of the most important 
advances in therapeutics; the main aim of these efforts is not only control the serious infections, but also 
prevention and treatment of some infectious complications of other therapeutic modalities. A series of 5-(2-
aroyl)aryloxy methyl-2-phenyl-1,3,4-oxadiazoles were screened for their antibacterial and antifungal activities. 
Anti-bacterial activity against B. cereus, S. aureus,  B. subtilis, S. aureus (MRSA),  E. aerogenes, M. luteus,  K. 
pneumonia, P. aeruginosa,  S. typhimurium, E. coli, paratyphi-B, P. vulgaris bacterial strains and anti-fungal 
activity against C. albicans, A.niger, F.solani, A.flavus, B.cinerea, C.krusei, M. pachydermatis, C.parapsilosis, 
F.moniliforme, C.gloeosporioides fungal strains were carried out. The bioassays indicated that most of the 
synthesized compounds showed potential antibacterial and anti-fungal activity. 
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INTRODUCTION 
 
Infectious diseases are still a major threat to public 
health despite the tremendous progress in human medicine and 
their control remains a huge challenge since vaccines are only 
available against a limited number of pathogens. Most of the 
current anti-infective suffers from considerable limitations in 
terms of antimicrobial spectrum and side-effects, and their 
widespread overuse has led to drug resistance (Fauci, 2001). 
Over the past few decades, the problems posed by multi-drug 
resistant microorganisms have reached an alarming level in many 
countries around the world. The use of most antimicrobial agents 
is limited, not only by the rapidly developing drug resistance, but                     
also by the unsatisfactory status of the present treatment of 
bacterial and fungal infections (Fidler, 1998; Hong, 2001; Oren 
et al., 1998). Infections caused by those microorganisms 
represent a serious challenge to the medical community; hence,                         
the development of new antimicrobial agents is an important 
goal.  
       . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In particular, increasing drug resistance among gram-
positive bacteria such as staphylococci, enterococci and 
streptococci is a significant health matter (Ramya, 2009). There is a 
real perceived need for the discovery of new compounds endowed 
with antimicrobial activities. The newly prepared compounds 
should be more effective and possibly act through a distinct 
mechanism from those of well-known classes of antimicrobial 
agents to which many clinically relevant pathogens are now 
resistant. During the past years extensive evidences have been 
accumulated to establish the efficiency of benzophenone analogues 
as antimicrobial agent (Khanum et al., 2005; Trusheva et al., 2004; 
Lokvam et al., 2000; Curtze et al., 1998). Benzophenone analogue 
used in central-African traditional medicine and this has been 
shown to exhibit chemotherapeutical activity against gram-positive 
and gram-negative cocci, mycobacteria and fungi (Bakana et al., 
1997). Recently Selvi et al have shown antifungal activity of 
benzophenone analogues, at its lower concentration (Tamil Selvi et 
al., 2003). Besides chloro substituted benzophenones have 
exhibited more antifungal activity (Grote et al., 2002). 1,3,4-
Oxadiazole is associated with potent pharmacological activity due 
to the presence of toxophoric N C O linkage (Rigo1985). 1,3,4-
oxadiazoles are biologically active,               . 
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synthetically useful and important heterocyclic compounds. 
Various biological activities are reported to be associated with 1, 
3, 4-oxadiazoles like antibacterial (Revanasiddappa and 
Subrahmanyam  2010) , antifungal (Hansong et al., 2002; Shetgiri 
and Nayak 2005) , anti inflammatory(Mohd Amir and Shikha 
Kumar  2003) etc., Similarly 2,5-disubstituted-1,3,4- oxadiazole 
derivatives possess broad spectrum of activities like antifungal 
(Adams et al., 1986), anticonvulsant (Omar et al., 1984)  , 
anticancer (Bhat et al., 1984)etc.,  Moreover, a large number of 
oxadiazoles ( Bhat et al., 2005; Sahin et al., 2002; Priya and 
Balakrishna Kalluraya  2005; Xia-Juan Zou et al., 2002) have been 
shown to exhibit significant antimicrobial activity against S. 
aureus, C. albicans, C. krusei, C. parapsilosis, T. paradoxa, E. 
Coli, B. subtilis and P. aeruginosa.  Encouraged by these reports 
the present study for antibacterial and antifungal activities has 
been undertaken for the synthesized compound (Khanum et al., 
2004). 
 
EXPERIMENTAL SECTION  
 
Chemistry 
Materials and Methods 
 Chemicals were purchased from Aldrich Chemical Co. 
TLC was performed on preactivated (110C) silica gel plates using  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hexane chloroform and acetone as eluent. Melting points were 
determined with Thomas Hoover capillary melting point apparatus 
and are uncorrected. A simple household microwave oven 
operating at 2450 MHz (power 900W), equipped with a turntable 
was used. IR spectra were recorded in Nujol on FT-IR Shimadzu 
8300 spectrophotometer, 1H NMR spectra were recorded on a 
Bruker 300 MHz NMR spectrophotometer in CDCl3 and chemical 
shifts were recorded in parts per million down field from 
tetramethylsilane. Mass spectra were obtained with a VG70-70H 
spectrophotometer. Elemental analysis results are within 0.4% of 
the calculated value. 
 
SYNTHESIS 
 
 5-(2-aroyl) aryloxy-methyl -2-phenyl-1, 3,4oxadiazoles (4a-e) 
Thermal method 
A mixture of 3a (0.5 g,  1.6 mmol) and benzoic acid 
(0.19 g, 1.6 mmol) in phosphorus oxy chloride (2 ml) was refluxed 
for 8 h at 120oC. The mixture was cooled and poured onto crushed 
ice, made basic by sodium-bi-carbonate solution and the resulting 
solid was filtered. The crude material was purified by 
chromatography on silica gel column using hexane/chloroform/ 
acetone (7:2:1, v/v) as an eluent. The solvent was removed under 
reduced pressure to afford 5-[2(3-chloro) benzoyl] phenoxy- 
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methyl-2-phenyl-1, 3, 4-oxadiazoles 5-[2(3-chlorobenzoyl)-4-
methylphenoxy] methyl-2-phenyl-1, 3, 4-oxadiazoles (4a). 
 
Microwave irradiation method 
In a typical synthetic procedure, a mixture of 3a (0.5 g, 
1.6 mmol), benzoic acid (0.19 g, 1.6 mmol) and clay (1:3 w/w)       
. 
was thoroughly mixed in the solid state using a vortex mixer and 
irradiated in an unmodified household microwave oven at its 50% 
power for 10 min. Upon completion of the reaction followed by 
TLC examination, the product was extracted into dichloromethane 
(320 ml), the combined organic extract dried with anhydrous 
sodium sulphate and solvent was removed under reduced pressure 
to afford pure 4a. The compounds 4a-e was characterized by IR, 
1H NMR and mass spectrophotometer (Khanum et al., 2004).   
 
BIOLOGY 
 
Materials and methods for the antimicrobial activity 
Streptomycin was used as positive controls against 
bacteria. ketoconazole (Himedia, Mumbai) were used as positive 
controls against fungi.  
 
Tested microbes 
The following gram positive bacteria were used for the 
experiments; B. cereus, staphylococcus aureus (MTCC 7443), B. 
subtilis, Staphylococcus aureus (MRSA) (MTCC 84),  
Enterobacter aerogenes (MTCC 111),  Micrococcus luteus 
(MTCC 1538). The gram negative bacteria included Klebsiella 
pneumoniae (MTCC 109), P. aeruginosa, Salmonella typhimurium 
(MTCC 2488), Escherichia coli, Salmonella paratyphi-B (MTCC 
733), Proteus vulgaris (MTCC 321). In addition, fungi  Candida 
albicans (MTCC 227), A.niger, F. solani, A.flavus, Botyritis 
cinerea (MTCC 2880), Candida krusei (MTCC 231), Malassesia 
pachydermatis, C.parapsilosis, F. moniliforme C. gloeosporioides 
were also used for the experiments. All cultures were obtained 
from the Department of Microbiology, Manasagangotri, Mysore.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preparation of inoculums 
Bacterial inoculums were prepared by growing cells in 
Mueller Hinton Broth (MHA) (Himedia) for 24 h at 37oC. These 
cell suspensions were diluted with sterile MHB to provide initial 
cell counts of about 104 CFU/ml. The filamentous fungi were 
grown on sabouraud dextrose agar (SDA) slants at 28oC for 10 
days and the spores were collected using sterile doubled distilled 
water and homogenized.  
 
Disc diffusion assay 
Antibacterial activity was carried out using a disc 
diffusion method (Murray 1995) Petri plates were prepared with 
20 ml of sterile Mueller Hinton Agar (MHA) (Himedia, Mumbai). 
The test cultures were swabbed on the top of the solidified media 
and allowed to dry for 10 mins. The tests were conducted at 1000 
µg/disc. The loaded discs were placed on the surface of the 
medium and left for 30 min at room temperature for compound 
diffusion. Negative control was prepared using respective solvent. 
Streptomycin (10 µg/disc) was used as positive control. The plates 
were incubated for 24 h at 37oC for bacteria and 48 h at 27oC for 
fungi. Zone of inhibition was recorded in millimeters and the 
experiment was repeated twice. 
 
Minimum inhibitory concentration (MIC) 
Minimum inhibitory concentration studies of synthesized 
compounds were performed according to the standard reference 
method for bacteria (Duraipandiyan and Ignacimuthu 2009) and 
filamentous fungi (Clinical and Laboratory Standards Institute 
2008). Required concentrations (1000 µg/ml, 500µg/ml, 250 
µg/ml, 125 µg/ml, 62.5 µg/ml, 31.25 µg/ml and 15.62 µg/ml) of 
the compound was dissolved in DMSO (2%), and diluted to give 
serial two-fold dilutions that were added to each medium in 96 
well plates. An inoculum of 100 ml from each well was 
inoculated. The anti-fungal agent’s ketoconazole, fluconazole for 
fungi and streptomycin, ciprofloxacin for bacteria were included in 
the assays as positive controls. For fungi, the plates were incubated 
Table.  1: Antibacterial activity of the compounds: 4a-e: MIC in µg /mL. 
Compounds Name of microorganism  (MIC in µg /mL) Gram positive bacteria Gram negative bacteria 
 B. cereus 
S. 
aureus 
B. 
subtilis 
S. aureus 
(MRSA) 
E. 
aerogens 
M. 
luteus 
K. 
pneumonia 
P. 
aeruginosa 
S. 
typhimurium 
E. 
coli 
S. 
Paratyphi-B 
P. 
vulgaris 
4a 4.68 9.37 9.37 4.68 18.75 9.37 9.37 18.75 18.75 4.68 9.37 9.37 
4b 9.37 4.68 9.37 9.37 9.37 18.75 9.37 9.37 4.68 9.37 9.37 18.75 
4c 18.75 18.75 18.75 9.73 18.75 9.37 18.75 18.75 18.75 9.73 18.75 9.37 
4d 18.75 9.37 18.75 9.37 18.75 9.37 18.75 9.37 9.37 9.37 18.75 18.75 
4e 4.68 18.75 9.37 18.75 9.37 9.37 9.37 9.37 9.37 4.68 9.37 18.75 
Streptomycin 2.34 2.34 4.68 1.17 2.34 2.34 4.68 4.68 2.34 2.34 4.68 4.68 
 
Table. 2:  Antifungal activity of the compounds: 4a-e MIC in µg /mL. 
Compounds 
Name of the microorganism  MIC in g /mL 
 
C. albicans A. niger 
F. 
solani 
A. 
flavus 
B. 
cinerea 
C. 
krusei 
M. 
pachydermatis 
C. 
parapsilosis 
F. 
moniliforme C. gloeosporioides 
4a 9.37 4.68 9. 37 18.75 18.75 9.37 9.37 18.75 9.37 4.68 
4b 9.37 4.68 9.37 9.37 9.37 9.37 9.37 4.68 18.75 9.37 
4c 18.75 18.75 18.75 9. 37 18.75 18.75 9. 37 18.75 18.75 18.75 
4d 18.75 9.37 18.75 9.37 18.75 18.75 18.75 9.37 9.37 9.37 
4e 18.75 4.68 9.37 18.75 9.37 9.37 9.37 18.75 18.75 18.75 
Ketoconazole 4.68 2.34 2.34 1.17 4.68 2.34 4.68 4.68 2.34 2.34 
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for 48-72 h at 28oC and for bacteria the plates were incubated for 
24 h at 37oC. The MIC for fungi was defined as the lowest extract 
concentration, showing no visible fungal growth after incubation 
time. 5 ml of tested broth was placed on the sterile MHA plates for 
bacteria and incubated at respective temperatures. The MIC for 
bacteria was determined as the lowest concentration of the 
compound inhibiting the visual growth of the test cultures on the 
agar plate. 
 
RESULT AND DISCUSSION  
 
 The reaction sequence for the title compounds is outlined 
in Scheme 1. Compounds 4a-e has been prepared as previously 
reported by our group (Khanum et al., 2004). The antimicrobial 
screenings of the synthesized compounds were undertaken using 
disc diffusion method. The screening results of the tested 
compounds against the gram negative bacteria (Klebsiella 
pneumoniae, P. aeruginosa, Salmonella typhimurium, Escherichia 
coli, Salmonella paratyphi-B, Proteus vulgaris), gram positive 
bacteria (B. cereus, Staphylococcus aureus, B. subtilis, 
Staphylococcus aureus (MRSA), Enterobacter aerogenes, 
Micrococcus luteus) in addition to the pathogenic fungi Candida 
albicans, A.niger, F. solani,  A. flavus  Botyritis  cinerea,  Candida  
krusei, Malassesia pachydermatis, C.parapsilosis, F. moniliforme 
C. gloeosporioides microorganisms  are summarized in Table 1 
and 2. The obtained data revealed that most of the compounds 
showed moderate to excellent activities against the tested 
microorganisms. Compounds 4a, 4b, 4e showed good activity 
among all the synthesized compounds compared with the standard 
drug. Compound 4a showed good bacterial activity against B. 
cereus, S. aureus (MRSA) and E. coli.  Compound 4b showed 
moderate activity against S. aureus and S. typhimurium and 
compound 4e against B. cereus and E. coli. Compound 4a with 
chloro group at the meta position in benzoyl ring and methyl group 
at para position in phenyl ring of benzophenone, 4b with bromo 
group at ortho position in benzoyl ring and methyl group at para 
position in phenyl ring of benzophenone and 4e with chloro group 
at meta position in benzoyl ring and para position in phenyl ring of 
benzophenone showed good activity against both gram-positive 
and gram-negative bacteria.  
Compound 4a showed significant antifungal activity 
against A. niger and C. gloeosporioides, Compound 4b showed 
activity against A.niger and C. parapsilosis and 4e showed activity 
against A.niger. Compound 4c and 4d without any halogen 
substituent exhibited lowest activity and this can be attributed to 
the electron releasing effect.  Significant MIC values were 
observed against gram positive, gram negative bacteria and 
antifungal activity. In comparison, compound 4a is more potent 
than 4b and 4b is more potent than 4e. In general, compound 4a 
showed better activity for most of the tested bacteria and fungi. 
 
CONCLUSION   
 
In conclusion, this study is with respect to synthesis of 5-
(2-aroyl)aryloxy methyl-2-phenyl-1,3,4-oxadiazoles analogues 4a-
e as new budding antimicrobials. These novel compounds were 
evaluated for their activities against twelve bacteria and ten fungi. 
Compound 4a with chloro group showed better activity for most of 
the tested bacteria and fungi. 
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